$ODYS

Market (ATM) Program of up to $20 Million to Enhance Financial Flexibility

Odysight.ai said it filed an SEC prospectus supplement for an at-the-market (ATM) program that could sell up to $20 million of its common stock from time to time at its discretion. The company will use Roth Capital Partners as sales agent. Odysight.ai said the program does not obligate share sales and pricing may vary with market conditions.

Original reporting
Published Jun 8, 2026, 6:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 6:43 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$ODYS
Neutral
medium confidence
Mentioned
$ODYS
Relevance
8/10
alphai data visualization · based on itnewsonline.com
Decision brief

The 30-second read

$ODYSNeutralMed
01

Why it matters

The key tradable variable is whether the ATM is activated and how much stock is sold, which would directly affect dilution and potentially liquidity/float dynamics.

02

Market read

Disclosed capacity for up to $20M of optional equity issuance via ATM, creating a dilution/overhang risk that can influence valuation and trading behavior.

03

What to watch

Because the company is not obligated to sell, traders should monitor actual ATM sales/settlements and the realized offering prices versus prevailing market levels.

Relevance 8/10Novelty 9/10Timing: Prospectus supplement filed June 5, 2026; PR published June 7, 2026.

Background

The company updated its shelf registration and filed a prospectus supplement enabling an at-the-market equity program.

Company-level read

Ticker impact

$ODYSNeutralMedium confidence
Context

Odysight.ai filed an SEC prospectus supplement for a $20M at-the-market (ATM) common-stock offering with Roth Capital Partners.

Expected impact

Near-term pressure possible if investors price in dilution risk; actual impact depends on whether/when shares are sold and at what prices.

Evidence & confidence

ATM programs are optional and execution is at management’s discretion, but the disclosed $20M capacity can still weigh on valuation expectations.

Market effects

Adds another small-cap/AI name using ATM financing, reinforcing ongoing reliance on equity capital for growth.

Dual listing mention (TASE) may broaden investor base, but the financing is U.S.-capital-market driven.

Limited direct global spillover; primarily affects Odysight.ai’s capital structure and near-term supply/dilution expectations.

Counterpoint

If the company can fund growth without heavy dilution (slow/limited ATM usage), the ATM may function more as a liquidity backstop than a near-term overhang.

Key entities

  • Odysight.ai

    Filed an SEC prospectus supplement for a $20M ATM offering of common stock.

  • Roth Capital Partners

    Named as sales agent for the ATM program.

  • SEC

    Received the prospectus supplement under the company’s shelf registration.

Related articles

$ODYSMed

Odysight.ai Receives Purchase Order from Elbit Systems on Behalf of the Israeli Ministry of Defense for Deployment of Its Vision-Based Prognostics and Health Management System

Odysight.ai Inc. (ODYS) said it received a purchase order from Elbit Systems for the Israeli Ministry of Defense to integrate its computer vision-based Prognostics and Health Management system. The order is valued at about $0.3 million (NIS 1.0 million). Odysight.ai said successful installation could enable broader deployment across Israeli Defense Forces platforms.

$ODYSMedAI 8/10

Odysight.ai Completes First U.S. Test Flights of its AI Visual Sensing System on UH-60 Black Hawk Helicopter

Odysight.ai said it completed the first U.S. test flights of its AI visual sensing system on a UH-60 Black Hawk helicopter with XP Services in Tennessee. The company said the system provided stable, real-time monitoring of hydraulic systems and flight controls and is designed for condition-based maintenance. Odysight.ai cited 4,000 UH-60s in service worldwide, about 2,800 in the U.S.

$SPCXMed

Why SpaceX Stock Just Gained 15.8%

Space Exploration Technologies Corp. (SpaceX, NASDAQ: SPCX) shares rose 15.8% on Friday, outperforming the S&P 500 and Nasdaq. The move followed the first tranche of an IPO lock-up expiring, with 911.5 million shares becoming eligible to trade, and a joint SpaceX and Tesla announcement of a $16.8 billion Texas Terafab semiconductor project.

$DOCSMed

Why Doximity Stock Skyrocketed on Friday

Doximity (NYSE: DOCS) shares rose after CEO Jeff Tangney said early returns from the company’s AI investments are improving profitability. In fiscal 2027 Q1 ended June 30, revenue increased 7% to $156.6M, while adjusted EBITDA fell 6% to $74.8M. Tangney cited >25% QoQ AI prompt volume growth and 10x AI Scribe users, plus revenue exceeding 10x search costs.

$BTGMedAI 8/10

B2Gold Shares Surge 23% After Mali Permit Boosts Fekola Growth Outlook

B2Gold’s shares (BTG) rose 23.1% to $5.03 on Aug. 7 after Mali issued the Menankoto permit for the Fekola mine. B2Gold said Fekola Regional targets over 150,000 ounces annually from 2028 and tightened 2026 production guidance to 820,000–920,000 ounces. Adjusted EPS was $0.03 vs $0.07 consensus; cash was $287m.